beta
(영문) 특허법원 2015.09.24 2015허758

권리범위확인(특)

Text

1. The decision made by the Intellectual Property Tribunal on December 30, 2014 on a case No. 2013Da3242 shall be revoked.

2. The costs of lawsuit shall be.

Reasons

1. Basic facts

A. On December 10, 2013, the Plaintiff filed a petition with the Intellectual Property Tribunal for a trial to confirm the scope of right by asserting that the invention in question falls under the scope of the right of patent invention 7 (hereinafter referred to as “instant Claim 7”) and does not fall under the scope of patent right of the instant patent invention. 2) The Intellectual Property Tribunal examined the instant petition for a trial as the case under 2013Da3242, and dismissed the petition for a trial on December 30, 2014 by a person with ordinary knowledge in the art to which the invention pertains (hereinafter referred to as “ordinary technician”), and the invention in question falls under the scope of patent right of the instant Claim 7 (hereinafter referred to as “instant Claim 7”), and the Plaintiff’s petition for a trial to confirm the scope of right of the instant patent invention.

B. The name of the Defendant’s patented invention of this case (Evidence 2) 1: The number of damages, i.e., people in the islands in the Ulllleungdo and South and North regions, in which the content of Dalin A and Dolin B increased. The country of origin is distributed overseas to Japan and China. The method of manufacturing extractions and the date of filing of the pharmaceutical products for treating Korean Ambassador diseases, and the date of filing of registration/registration number: the date of registration/registration number: Claim 1 through 6, and 8 (No. 93080, Dec. 17, 2009) claims, i.e., claims 1 through 6, and 8 (no. subject to the instant claim for adjudication, and the description is omitted).

【Claims 7】 Chemical structural compound A or multi-water B compounds, characterized by which one or more of the chemical structural compounds is contained as active ingredients, and the composition of pharmacy for improvement and treatment of urine urine or urine urine urine urine urine urine or urine urine urine urine -

(c) the name of the invention in question (as amended on May 29, 2014): the use of the title of the invention in question, including the non-part extractions, for improvement.